A Message fromKaitlyn Proulx Managing Director, PDCI Market Access
I am thrilled to be sharing the news of the recent acquisition of PDCI Market Access by McKesson Canada Corporation. Over the years, PDCI has continued to grow and thrive ... Read More
07
Dec2020
04
Nov2020
Last week, the PMPRB announced that they would be hosting a public webinar for all its stakeholders in order to communicate the key elements within the Final Guidelines and to address questions. The webinar was originally scheduled for November 10, 2020 but has been rescheduled to November ... Read More
28
Oct2020
PDCI Market Access is hosting a free webinar for pharmaceutical industry members on the final Guidelines released by the PMPRB on October 23rd, 2020. PDCI has released a summary on the key highlights of the final Guidelines and the PDCI ... Read More
30
Sep2020
Over the last few months, PDCI Market Access Inc., Connex Health and H3 Consulting have undertaken an initiative to better understand the Canadian private payer product listing agreement (PLA) landscape and how it has evolved ... Read More
30
Sep2020
PDCI-PLA-Study-Report-PDCI-Market-Access-Inc.-Connex-Health-Consulting-H3-ConsultingDownload
25
Sep2020
At PDCI Market Access Inc., our vision at PDCI is to be your most trusted and valued pricing and reimbursement strategic partner. To ensure we continue to meet the strategic needs of our customers in the face of the ever-changing Canadian reimbursement landscape, we’ve expanded our Health Economic ... Read More
10
Sep2020
PDCI Market Access is
pleased to release our premier issue of PDCI
Market Access INSIGHTS online journal to
our Market Access Toolkit subscribers. The articles in our first issue provide
deep dives into:
Planning and budgeting PSPs during the pandemic,New data and new perspectives on private insurers and ... Read More
09
Sep2020
The August 2020 issue of Cell & Gene Therapy Insights, has a focus on Market access: evolving commercialization trends and strategies. PDCI Market Access’ very own Neil Palmer is featured as a guest editor and the author of the article, Under construction: roadmaps for HTA, pricing and ... Read More
09
Sep2020
Palmer-Cell-and-Gene-Theraoy-InsightsDownload
07
Jul2020
PDCI Market Access Inc. is pleased to share its best practices infographic focused on Requesting Reconsideration under the Canadian Agency for Drugs and Technologies in Health (CADTH) Procedures for the Common Drug Review (CDR). While optional and only appropriate in select circumstances, manufacturers should not overlook this potential opportunity ... Read More